TIBER CREEK GROUP for JAZZ PHARMACEUTICALS
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Budget/Appropriations BUD
Appropriations issues related to the FDA enforcement of non-FDA approved CBD products; FY 2022 Agriculture, Food and Drug Administration Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Medical/Disease Research/Clinical Labs MED
Issues related to the FDA and S. 3032 - the FDA STATES Act, and Health and Human Services pertaining to CBD policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN MICHAEL GONZALEZ | — |
| EMILY KIRLIN | — |
| MATTHEW LEFFINGWELL | — |
| TIMOTHY A MOLINO | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.